MBIO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.21%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Mustang Bio Insider Trading History Chart

Mustang Bio Share Price & Price History

^$1.32

▲ +0.13 (10.92%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Mustang Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/18/2023	Manuel Litchman	Director	Buy	6	$555.00	$3,330.00	1,377

SEC Filings (Institutional Ownership Changes) for Mustang Bio (NASDAQ:MBIO)

9.95% of Mustang Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Mustang Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/28/2025	Anson Funds Management LP	45,716	$57K	0.0%	N/A	1.044%
5/14/2025	Anson Funds Management LP	45,716	$57K	0.0%	N/A	1.383%
2/12/2025	Geode Capital Management LLC	284,437	$50K	0.0%	+15.9%	29.629%
8/8/2024	Thoroughbred Financial Services LLC	53,000	$25K	0.0%	N/A	0.423%
8/6/2024	Koss Olinger Consulting LLC	98,366	$47K	0.0%	N/A	0.786%
5/20/2024	Virtu Financial LLC	30,176	$31K	0.0%	N/A	0.290%
2/13/2024	Armistice Capital LLC	435,764	$0.59M	0.0%	N/A	4.726%
7/31/2023	Koss Olinger Consulting LLC	100,000	$0.62M	0.1%	N/A	1.225%
7/27/2023	B. Riley Wealth Advisors Inc.	10,240	$64K	0.0%	N/A	0.125%
5/10/2023	Oppenheimer & Co. Inc.	91,982	$34K	0.0%	-11.6%	1.251%
5/1/2023	Arete Wealth Advisors LLC	15,538	$5.70B	0.0%	N/A	0.211%
2/8/2023	Oppenheimer & Co. Inc.	104,077	$41K	0.0%	-14.0%	0.098%
11/18/2022	Spotlight Asset Group Inc.	305,312	$0.14M	0.1%	N/A	0.288%
11/14/2022	Ergoteles LLC	288,934	$0.14M	0.0%	-14.4%	0.272%
11/14/2022	Oppenheimer & Co. Inc.	120,980	$57K	0.0%	+168.9%	0.114%
11/7/2022	Western Wealth Management LLC	90,000	$42K	0.0%	N/A	0.085%
8/15/2022	Laurion Capital Management LP	1,445,600	$0.85M	0.0%	N/A	1.403%
8/12/2022	Ikarian Capital LLC	246,824	$0.15M	0.0%	-54.9%	0.240%
5/11/2022	GSA Capital Partners LLP	1,216,445	$1.23M	0.2%	-7.7%	1.213%
5/2/2022	National Asset Management Inc.	310,926	$0.32M	0.0%	+16.1%	0.310%
2/15/2022	Sassicaia Capital Advisers LLC	15,500	$26K	0.2%	N/A	0.017%
2/14/2022	GSA Capital Partners LLP	1,318,400	$2.19M	0.3%	+135.3%	1.411%
2/9/2022	Dimensional Fund Advisors LP	927,589	$1.54M	0.0%	-12.3%	0.993%
2/8/2022	ProShare Advisors LLC	28,907	$48K	0.0%	N/A	0.031%
2/8/2022	Northern Trust Corp	617,969	$1.03M	0.0%	-8.5%	0.661%
2/7/2022	SG Americas Securities LLC	19,958	$33K	0.0%	-52.1%	0.021%
2/7/2022	Arete Wealth Advisors LLC	15,538	$26K	0.0%	N/A	0.017%
2/4/2022	Envestnet Asset Management Inc.	42,311	$70K	0.0%	+139.3%	0.045%
2/3/2022	Los Angeles Capital Management LLC	136,876	$0.23M	0.0%	+24.7%	0.147%
2/2/2022	PVG Asset Management Corp	14,870	$25K	0.1%	N/A	0.016%
1/28/2022	National Asset Management Inc.	267,836	$0.45M	0.0%	+5.7%	0.287%
11/16/2021	National Asset Management Inc.	253,275	$0.68M	0.0%	+7.2%	0.277%
11/16/2021	Two Sigma Advisers LP	1,235,200	$3.32M	0.0%	-13.7%	1.351%
11/16/2021	Two Sigma Investments LP	948,415	$2.55M	0.0%	-29.3%	1.038%
11/16/2021	Telemetry Investments L.L.C.	125,000	$0.34M	0.5%	N/A	0.137%
11/15/2021	Dimensional Fund Advisors LP	1,058,259	$2.85M	0.0%	-28.3%	1.158%
11/15/2021	GSA Capital Partners LLP	560,215	$1.51M	0.2%	+117.0%	0.613%
11/12/2021	Renaissance Technologies LLC	487,400	$1.31M	0.0%	+3,106.6%	0.533%
11/12/2021	Hsbc Holdings PLC	60,226	$0.16M	0.0%	+424.6%	0.066%
11/12/2021	Oppenheimer & Co. Inc.	46,588	$0.13M	0.0%	-69.7%	0.051%
11/12/2021	Geode Capital Management LLC	1,346,126	$3.62M	0.0%	+11.3%	1.473%
11/10/2021	Goldman Sachs Group Inc.	248,606	$0.67M	0.0%	+210.0%	0.272%
11/9/2021	Barclays PLC	89,663	$0.24M	0.0%	+79.0%	0.098%
11/9/2021	BlackRock Inc.	5,017,614	$13.50M	0.0%	+1.6%	5.490%
11/8/2021	Russell Investments Group Ltd.	441,818	$1.19M	0.0%	N/A	0.483%
11/8/2021	Los Angeles Capital Management LLC	109,726	$0.30M	0.0%	+5.3%	0.120%
11/4/2021	Financial Advocates Investment Management	38,925	$0.11M	0.0%	+43.1%	0.043%
11/1/2021	SG Americas Securities LLC	41,639	$0.11M	0.0%	N/A	0.046%
8/16/2021	Goldman Sachs Group Inc.	80,190	$0.27M	0.0%	-80.7%	0.092%

Data available starting January 2016

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.

Today's Range

Now: $1.32

$1.18

$1.33

50 Day Range

MA: $1.41

$1.15

$1.77

52 Week Range

Now: $1.32

$0.89

$21.95

Volume

98,247 shs

Average Volume

96,172 shs

Market Capitalization

$9.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.08